Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : IMRS A Y2K FIRM SUCCESSFULLY REPOSITIONING ITSELF -- Ignore unavailable to you. Want to Upgrade?

To: Nanda who wrote (77)	2/22/1999 7:37:00 PM
From: paul e thomas	Read Replies (2) \| Respond to of 188

Nanda,thanks. I really got killed with February options.Take a look at CURE.I have followed this company for a number of years first bought at 4 .It collapsed recently way excessively even when it met analyst expectations.The analysts over reacted to conference call statement by CEO earnings were going to slow in 1999.Check out news releases pointing out that in previous years they had major tax loss credits.I don't have money to buy my self. I touted stock 2 days ago to neighbor who was visiting me in Florida. She bought at 11 1/2 now 13+.Stock has little downside risk as cash per share is 5$ and wound care market is recession resistant. The management is top notch from a marketing point of view. Transformed company from product oriented to extremely successful,TV advertising medical service company.IF I keep talking like this I might sell my IMRS to buy it.Health Care stocks are hot right now. I follow a number I have bought in the past.